GILD PEER ANALYSIS

Gilead Sciences Inc — metric-by-metric comparison with peers and the industry median

GILDGilead Sciences Inc

🇺🇸 USA · US · Healthcare · Drug Manufacturers - General

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - General

Position Within Industry

0 = weak quartile, 100 = strong quartile

GILDIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	GILD	SAN	BAYN	AZN	GRF	AZN	Ind. Median
P/E	17.64	8.66●	—	28.27	14.86	28.08	22.54
P/B	6.91	1.23	1.74	6.20	1.13●	6.20	4.53
EV/EBITDA	12.07	9.57●	23.53	15.69	10.53	15.57	13.48
P/S	5.47	1.93	1.11	4.86	0.83●	4.83	3.14

Financial Health
Metric	GILD	SAN	BAYN	AZN	GRF	AZN	Ind. Median
Current Ratio	1.97	1.01	1.06	0.91	2.47●	0.91	1.25
Debt/Equity	94.3%	27.5%●	134.8%	71.7%	177.2%	71.7%	94.3%
NetDebt/EBITDA	0.85●	1.33	9.19	1.29	6.22	1.28	1.35

Profitability
Metric	GILD	SAN	BAYN	AZN	GRF	AZN	Ind. Median
Net Margin	31.0%●	22.3%	-4.8%	17.2%	5.6%	17.2%	15.0%
ROE	43.2%●	14.1%	-7.0%	23.5%	7.5%	23.7%	23.7%
ROA	16.4%●	8.0%	-2.0%	9.4%	2.0%	9.5%	8.0%
EBITDA Margin	48.7%●	23.4%	7.7%	33.7%	19.3%	33.8%	28.4%

Growth + Dividend
Metric	GILD	SAN	BAYN	AZN	GRF	AZN	Ind. Median
Rev. Growth	3.5%	3.3%	-2.9%	9.9%●	0.9%	9.7%	3.3%
NI Growth	54.5%	59.8%	—	33.7%	112.7%●	32.9%	32.9%
Div. Yield	2.5%●	0.0%	0.2%	0.2%	2.1%	2.2%	2.1%
Payout	43.8%	0.0%	-5.9%	47.3%	30.8%	47.0%	45.7%

Valuation
Metric	GILD	PFE	AMGN	BMY	MRK	ABBV	Ind. Median
P/E	17.64	18.15	25.56	15.92●	35.08	124.19	22.54
P/B	6.91	1.51	21.69	5.77	6.83	-68.35●	4.53
EV/EBITDA	12.07	11.18	14.66	10.90●	19.00	30.46	13.48
P/S	5.47	2.15●	5.35	2.39	4.78	7.19	3.14

Financial Health
Metric	GILD	PFE	AMGN	BMY	MRK	ABBV	Ind. Median
Current Ratio	1.97●	1.25	1.26	1.42	1.30	0.80	1.25
Debt/Equity	94.3%	71.5%	623.8%	221.5%	107.1%	-1,101.9%●	94.3%
NetDebt/EBITDA	0.85●	3.07	2.71	2.47	2.31	3.75	1.35

Profitability
Metric	GILD	PFE	AMGN	BMY	MRK	ABBV	Ind. Median
Net Margin	31.0%●	11.8%	20.9%	15.0%	13.6%	5.8%	15.0%
ROE	43.2%	8.3%	101.3%●	38.8%	19.0%	—	23.7%
ROA	16.4%●	3.6%	8.6%	8.1%	7.3%	2.7%	8.0%
EBITDA Margin	48.7%●	26.5%	44.8%	28.4%	28.6%	26.9%	28.4%

Growth + Dividend
Metric	GILD	PFE	AMGN	BMY	MRK	ABBV	Ind. Median
Rev. Growth	3.5%	1.4%	9.1%	1.8%	2.5%	9.5%●	3.3%
NI Growth	54.5%●	-4.8%	31.5%	34.2%	-48.7%	-13.3%	32.9%
Div. Yield	2.5%	7.2%●	2.7%	4.5%	2.6%	2.7%	2.1%
Payout	43.8%	130.5%	66.7%	69.7%	92.1%	324.8%	45.7%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on GILD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.